Biotechforum conferences

Moderado por: Lucía Roales Escudero. Periodista

20th September

10:00 – 11:00

OPENING OF THE CONGRESS

Basic biomedical research is a guarantee of being able to generate new drugs and/or therapeutic strategies that reach the population to solve pathologies for which there is currently no cure

• Ion Arocena. General Manager ASEBIO.
• Prof. Agustín Zapata González. Deputy Coordinator of the Spanish Network of Advanced Therapies (TERAV) of the Carlos III Institute of Health. Professor of Cell Biology. Complutense University of Madrid.
• Julio Martínez. Project Manager at BIOGA.

Conference sponsored by:

11:00 – 12:00

New advances in the field of Advanced Therapies

• Prof. Nuria Montserrat. Research Professor. ICREA. Institute for Bioengineering of Catalonia (IBEC). Director of the Biobanks Platform (ISCIII) and Coordinator of the Technological Developments program of the Spanish Network of Advanced Therapies of the ISCIII (TERAV).
• Prof. Rut Valdor Alonso. Ramón y Cajal Researcher, University of Murcia. Member of the Transplantation and Cell Therapy Unit of the Hospital Clínico Universitario Virgen de la Arrixaca, Murcia. Researcher at IMIB-Arrixaca. Murcia.

12:00 – 12:30

COFFEE BREAK

12:30 – 14:00

Facilities and closed systems for the production of Advanced Therapies

• Dr. Nuria Marí. Director of R&D at Aglaris Cell.
• María Eugenia Fernández. Director of Cell Production Unit, Hospital General Universitario Gregorio Marañón.
• Javier Alonso. General Manager LITEK PHARMA.
• Jordi Gibert Amat, Head of the Biotechnology Unit at Klinea BioPharmaceutical Engineering.

Table Sponsored by:

14:00 – 15:00

LUNCH BREAK

15:30 – 16:30

Gene therapy products and derivatives: CAR-T cells

• Dr. Ander Izeta. Instituto Biodonostia.
• Dr. Josep M Canals. Director of CREATIO.
• Dr. Jose Luis Mateos. Miltenyi Biotech.
• Dr. Sergi Querol. Banc de Sang i Teixits.

Conference Sponsored by:

16:30 – 17:30

The regulatory framework of restriction enzymes, plasmids, viral vectors and radiolabeled CART-T cells

• Francisco Manuel Reyes Sosa. Business Development Manager at 53Biologics.
• Marcos Timón. Head of Unit (Advanced Therapies and Biotechnology) at AEMPS (Spanish Medicines Agency).
• Carlos Langeber Gavilán. CEO and co-founder of YSOTOPE THERANOSTICS.
• VIVE BIOTECH.

Conference Sponsored by:

17:30 – 18:30

The voice and vote of patients’ associations for the arrival of new drugs in the national health system

• Marcos Martínez. GEPAC.
• Dr. Joaquím Martinez. Scientific Director of CRIS against cancer.
• Marta Cardona. General Director of the CRIS Against Cancer Foundation.

21st September

10:00 – 11:00

The importance and regulation of Big Data in new in vitro diagnostic medical devices

• Dr. Santiago Barrio, Cofundador y CEO at Altum sequencing.
• Yolanda Sánchez. Account Manager Key Account – Agilent Technologies.
• Ascensión Hernández. Director Quality Assurance & Regulatory Affairs at Deepull Diagnostics.
• Martí Verdejo. CEO and founder of SPORTSWAPS.

11:00 – 12:00

New advances in Cell Therapy: Secretomes, exosomes and biomolecules. New regulatory protections and production systems

• Francisco Juste. Vice-president of Grupo JUSTE.
• Dr. Almudena Pradera. Chief Scientific Officer at EquiCord.
• Dr Joaquim Vives. Servei de Teràpia Cel-lular Banc de Sang i Teixits.
• Dra. Clara Boces. Head of R&D Department at Cellab.

12:00 – 12:30

COFFEE BREAK

12:30 – 13:30

Regulatory protection and new advances in microbiota, probiotics and prebiotics

• Dra. Noelia Martínez. Director of R+D+i at MicroViable Therapeutics.
• Dr. Juan-Evangelista Ruiz de Burgos.
• Dr. Javier Raboso. Responsable área de I+D+I en KONEXIO BIOTECH.
• Mariano Oto, CEO at Nucaps.

13:30 – 14:30

The importance of intellectual property protection in the development of business in biocompanies. Strategies for seeking public/private funding

• Dra. Lorena Vega. European patent Attorney at Clarke Modet.
• Borja Smith. General Manager of Bioinnova Consulting.
• Francisco Javier Tejero. General Manager of Matraz Innova.

14:30 – 15:30

LUNCH BREAK

15:30 – 16:30

New technologies to accelerate drug discovery and preclinical testing

• Manuela Berlanga. Business Developer at Celtarys Research.
• Dr. Bruno K. Rodiño Janeiro. Chief Scientific Officer at BFlow.Dr. María de la Fuente Freire. CEO at Diversa Technologies.